These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18584979)

  • 1. Evaluation of solid dispersions on a molecular level by the Raman mapping technique.
    Furuyama N; Hasegawa S; Hamaura T; Yada S; Nakagami H; Yonemochi E; Terada K
    Int J Pharm; 2008 Sep; 361(1-2):12-8. PubMed ID: 18584979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uniformity and physical states of troglitazone in solid dispersions determined by electron probe microanalysis and microthermal analysis.
    Hasegawa S; Hamaura T; Furuyama N; Horikawa S; Kusai A; Yonemochi E; Terada K
    Int J Pharm; 2004 Aug; 280(1-2):39-46. PubMed ID: 15265545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of solid state form of troglitazone by solid state NMR spectroscopy.
    Suzuki N; Kawasaki T
    J Pharm Biomed Anal; 2005 Feb; 37(1):177-81. PubMed ID: 15664759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method.
    Hasegawa S; Hamaura T; Furuyama N; Kusai A; Yonemochi E; Terada K
    Int J Pharm; 2005 Sep; 302(1-2):103-12. PubMed ID: 16102926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of physical properties of troglitazone crystal on the molecular interaction with PVP during heating.
    Hasegawa S; Furuyama N; Yada S; Hamaura T; Kusai A; Yonemochi E; Terada K
    Int J Pharm; 2007 May; 336(1):82-9. PubMed ID: 17178201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical property of troglitazone, an equal mixture of four stereoisomers.
    Suzuki N; Kasahara K; Hasegawa H; Kawasaki T
    Int J Pharm; 2002 Nov; 248(1-2):71-80. PubMed ID: 12429461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical and crystal structure analyses of the antidiabetic agent troglitazone.
    Kobayashi K; Fukuhara H; Hata T; Sekine A; Uekusa H; Ohashi Y
    Chem Pharm Bull (Tokyo); 2003 Jul; 51(7):807-14. PubMed ID: 12843587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix.
    Karavas E; Georgarakis M; Docoslis A; Bikiaris D
    Int J Pharm; 2007 Aug; 340(1-2):76-83. PubMed ID: 17478064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
    Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the solid-state forms of fenofibrate--a spectroscopic and computational study.
    Heinz A; Gordon KC; McGoverin CM; Rades T; Strachan CJ
    Eur J Pharm Biopharm; 2009 Jan; 71(1):100-8. PubMed ID: 18590814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-state variation of troglitazone drug substance by using a different recrystallization method.
    Suzuki N; Kasahara K; Watanabe Y; Kinoshita S; Hasegawa H; Kawasaki T
    Drug Dev Ind Pharm; 2003 Aug; 29(7):805-12. PubMed ID: 12906338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raman spectroscopy for quantitative analysis of pharmaceutical solids.
    Strachan CJ; Rades T; Gordon KC; Rantanen J
    J Pharm Pharmacol; 2007 Feb; 59(2):179-92. PubMed ID: 17270072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of lactose crystallinity using Raman spectroscopy.
    Murphy BM; Prescott SW; Larson I
    J Pharm Biomed Anal; 2005 Jun; 38(1):186-90. PubMed ID: 15907639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of solid dispersions of paracetamol and EUDRAGIT E prepared by hot-melt extrusion using thermal, microthermal and spectroscopic analysis.
    Qi S; Gryczke A; Belton P; Craig DQ
    Int J Pharm; 2008 Apr; 354(1-2):158-67. PubMed ID: 18242020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microwave generated solid dispersions containing Ibuprofen.
    Moneghini M; Bellich B; Baxa P; Princivalle F
    Int J Pharm; 2008 Sep; 361(1-2):125-30. PubMed ID: 18573321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A theoretical and spectroscopic study of gamma-crystalline and amorphous indometacin.
    Strachan CJ; Rades T; Gordon KC
    J Pharm Pharmacol; 2007 Feb; 59(2):261-9. PubMed ID: 17270079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [X-ray diffractometry in the analysis of drugs and pharmaceutical forms].
    Bettinetti GP
    Boll Chim Farm; 1989 May; 128(5):149-62. PubMed ID: 2690894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Process analytical applications of Raman spectroscopy.
    Rantanen J
    J Pharm Pharmacol; 2007 Feb; 59(2):171-7. PubMed ID: 17270071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.